Bruce Jackson
Stock Analyst at Benchmark
(1.13)
# 3,814
Out of 5,124 analysts
124
Total ratings
31.86%
Success rate
-16.1%
Average return
Main Sectors:
Stocks Rated by Bruce Jackson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CV CapsoVision | Maintains: Speculative Buy | $5 → $14 | $10.69 | +30.96% | 2 | Dec 31, 2025 | |
| ABT Abbott Laboratories | Initiates: Buy | $145 | $125.29 | +15.73% | 1 | Oct 10, 2025 | |
| BFRI Biofrontera | Maintains: Buy | $7 → $2.75 | $0.57 | +382.46% | 8 | May 19, 2025 | |
| HUMA Humacyte | Maintains: Buy | $17 → $14 | $0.96 | +1,357.57% | 15 | May 14, 2025 | |
| HBIO Harvard Bioscience | Maintains: Speculative Buy | $4.5 → $3 | $0.67 | +348.56% | 6 | May 13, 2025 | |
| CLNN Clene | Maintains: Buy | $84 → $33 | $5.87 | +462.18% | 8 | May 8, 2025 | |
| GNLX Genelux | Maintains: Speculative Buy | $25 → $23 | $4.36 | +427.52% | 7 | May 8, 2025 | |
| BLTE Belite Bio | Reiterates: Buy | $80 | $159.96 | -49.99% | 9 | Mar 26, 2025 | |
| NEO NeoGenomics | Reiterates: Hold | n/a | $11.76 | - | 8 | Jan 16, 2025 | |
| EXAS Exact Sciences | Reiterates: Buy | $65 | $101.56 | -36.00% | 7 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $0.26 | - | 3 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $30 | $5.77 | +419.93% | 8 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $1.25 | $0.27 | +357.88% | 2 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $3 | $0.99 | +203.03% | 3 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $5 | $1.34 | +274.53% | 4 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $300 | $8.31 | +3,510.11% | 2 | Sep 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $60 | $2.71 | +2,114.02% | 5 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $17 | $0.28 | +5,993.19% | 4 | Aug 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $24 | $0.95 | +2,422.33% | 3 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $5 | $0.36 | +1,273.25% | 4 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.39 | - | 7 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $23.09 | - | 7 | Sep 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Speculative Buy | $800 | $3.09 | +25,789.97% | 1 | Aug 8, 2022 |
CapsoVision
Dec 31, 2025
Maintains: Speculative Buy
Price Target: $5 → $14
Current: $10.69
Upside: +30.96%
Abbott Laboratories
Oct 10, 2025
Initiates: Buy
Price Target: $145
Current: $125.29
Upside: +15.73%
Biofrontera
May 19, 2025
Maintains: Buy
Price Target: $7 → $2.75
Current: $0.57
Upside: +382.46%
Humacyte
May 14, 2025
Maintains: Buy
Price Target: $17 → $14
Current: $0.96
Upside: +1,357.57%
Harvard Bioscience
May 13, 2025
Maintains: Speculative Buy
Price Target: $4.5 → $3
Current: $0.67
Upside: +348.56%
Clene
May 8, 2025
Maintains: Buy
Price Target: $84 → $33
Current: $5.87
Upside: +462.18%
Genelux
May 8, 2025
Maintains: Speculative Buy
Price Target: $25 → $23
Current: $4.36
Upside: +427.52%
Belite Bio
Mar 26, 2025
Reiterates: Buy
Price Target: $80
Current: $159.96
Upside: -49.99%
NeoGenomics
Jan 16, 2025
Reiterates: Hold
Price Target: n/a
Current: $11.76
Upside: -
Exact Sciences
Jan 13, 2025
Reiterates: Buy
Price Target: $65
Current: $101.56
Upside: -36.00%
Nov 22, 2024
Reiterates: Hold
Price Target: n/a
Current: $0.26
Upside: -
Nov 22, 2024
Reiterates: Speculative Buy
Price Target: $30
Current: $5.77
Upside: +419.93%
Nov 20, 2024
Reiterates: Speculative Buy
Price Target: $1.25
Current: $0.27
Upside: +357.88%
Oct 11, 2024
Reiterates: Speculative Buy
Price Target: $3
Current: $0.99
Upside: +203.03%
Oct 10, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $1.34
Upside: +274.53%
Sep 4, 2024
Reiterates: Speculative Buy
Price Target: $300
Current: $8.31
Upside: +3,510.11%
Aug 27, 2024
Reiterates: Speculative Buy
Price Target: $60
Current: $2.71
Upside: +2,114.02%
Aug 26, 2024
Reiterates: Speculative Buy
Price Target: $17
Current: $0.28
Upside: +5,993.19%
Aug 14, 2024
Reiterates: Speculative Buy
Price Target: $24
Current: $0.95
Upside: +2,422.33%
Mar 21, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $0.36
Upside: +1,273.25%
Nov 14, 2023
Downgrades: Hold
Price Target: n/a
Current: $1.39
Upside: -
Sep 15, 2023
Downgrades: Hold
Price Target: n/a
Current: $23.09
Upside: -
Aug 8, 2022
Initiates: Speculative Buy
Price Target: $800
Current: $3.09
Upside: +25,789.97%